Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 1.365.704
Filtrar
1.
Recurso na Internet em Português | LIS - Localizador de Informação em Saúde | ID: lis-48160

RESUMO

No Dia Mundial da Saúde, celebrado nesta quarta-feira (7/4), o Ministério da Saúde reforça a importância dos cuidados necessários para evitar a transmissão da covid-19 e destaca a importância da colaboração de cada um no enfrentamento da pandemia.


Assuntos
Pandemias/prevenção & controle , Vacinação , Atenção à Saúde
2.
Recurso na Internet em Português | LIS - Localizador de Informação em Saúde | ID: lis-48161

RESUMO

O Ministro da Saúde, Marcelo Queiroga, reuniu-se nesta terça-feira (6/4) com a Diretora da Organização Pan-Americana da Saúde (OPAS), Dra. Carissa Etienne, para discutir as ações de cooperação entre o Brasil e a organização, em especial de políticas de enfrentamento da Covid-19 e ações de vacinação.


Assuntos
Infecções por Coronavirus/prevenção & controle , Vacinação , Organização Pan-Americana da Saúde , Betacoronavirus
3.
Recurso na Internet em Português | LIS - Localizador de Informação em Saúde | ID: lis-48164

RESUMO

Um estudo feito no estado do Amazonas pelo grupo VEBRA COVID-19 (Vaccine Effectiveness in Brazil Against COVID-19) mostrou que a vacina CoronaVac tem efetividade de 50% na prevenção de adoecimento por COVID-19 após 14 dias da primeira dose


Assuntos
Infecções por Coronavirus/prevenção & controle , Vacinas/imunologia , Organização Pan-Americana da Saúde , Avaliação da Pesquisa em Saúde , Efetividade
4.
MMWR Morb Mortal Wkly Rep ; 70(13): 473-477, 2021 Apr 02.
Artigo em Inglês | MEDLINE | ID: mdl-33793457

RESUMO

Incarcerated and detained persons are at increased risk for acquiring COVID-19. However, little is known about their willingness to receive a COVID-19 vaccination. During September-December 2020, residents in three prisons and 13 jails in four states were surveyed regarding their willingness to receive a COVID-19 vaccination and their reasons for COVID-19 vaccination hesitancy or refusal. Among 5,110 participants, 2,294 (44.9%) said they would receive a COVID-19 vaccination, 498 (9.8%) said they would hesitate to receive it, and 2,318 (45.4%) said they would refuse to receive it. Willingness to receive a COVID-19 vaccination was lowest among Black/African American (Black) (36.7%; 510 of 1,390) persons, participants aged 18-29 years (38.5%; 583 of 1,516), and those who lived in jails versus prisons (43.7%; 1,850 of 4,232). Common reasons reported for COVID-19 vaccine hesitancy were waiting for more information (54.8%) and efficacy or safety concerns (31.0%). The most common reason for COVID-19 vaccination refusal was distrust of health care, correctional, or government personnel or institutions (20.1%). Public health interventions to improve vaccine confidence and trust are needed to increase vaccination acceptance by incarcerated or detained persons.


Assuntos
/administração & dosagem , Aceitação pelo Paciente de Cuidados de Saúde/psicologia , Prisioneiros/psicologia , Vacinação/psicologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , /prevenção & controle , Surtos de Doenças/prevenção & controle , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Prisioneiros/estatística & dados numéricos , Prisões , Fatores Socioeconômicos , Inquéritos e Questionários , Estados Unidos/epidemiologia , Adulto Jovem
5.
MMWR Morb Mortal Wkly Rep ; 70(13): 495-500, 2021 Apr 02.
Artigo em Inglês | MEDLINE | ID: mdl-33793460

RESUMO

Messenger RNA (mRNA) BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) COVID-19 vaccines have been shown to be effective in preventing symptomatic COVID-19 in randomized placebo-controlled Phase III trials (1,2); however, the benefits of these vaccines for preventing asymptomatic and symptomatic SARS-CoV-2 (the virus that causes COVID-19) infection, particularly when administered in real-world conditions, is less well understood. Using prospective cohorts of health care personnel, first responders, and other essential and frontline workers* in eight U.S. locations during December 14, 2020-March 13, 2021, CDC routinely tested for SARS-CoV-2 infections every week regardless of symptom status and at the onset of symptoms consistent with COVID-19-associated illness. Among 3,950 participants with no previous laboratory documentation of SARS-CoV-2 infection, 2,479 (62.8%) received both recommended mRNA doses and 477 (12.1%) received only one dose of mRNA vaccine.† Among unvaccinated participants, 1.38 SARS-CoV-2 infections were confirmed by reverse transcription-polymerase chain reaction (RT-PCR) per 1,000 person-days.§ In contrast, among fully immunized (≥14 days after second dose) persons, 0.04 infections per 1,000 person-days were reported, and among partially immunized (≥14 days after first dose and before second dose) persons, 0.19 infections per 1,000 person-days were reported. Estimated mRNA vaccine effectiveness for prevention of infection, adjusted for study site, was 90% for full immunization and 80% for partial immunization. These findings indicate that authorized mRNA COVID-19 vaccines are effective for preventing SARS-CoV-2 infection, regardless of symptom status, among working-age adults in real-world conditions. COVID-19 vaccination is recommended for all eligible persons.


Assuntos
/imunologia , Socorristas , Pessoal de Saúde , Doenças Profissionais/prevenção & controle , Ocupações/classificação , Adolescente , Adulto , /administração & dosagem , Socorristas/estatística & dados numéricos , Feminino , Pessoal de Saúde/estatística & dados numéricos , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Estados Unidos/epidemiologia , Vacinas Sintéticas/imunologia , Adulto Jovem
6.
Sensors (Basel) ; 21(7)2021 Mar 24.
Artigo em Inglês | MEDLINE | ID: mdl-33805218

RESUMO

The COVID-19 epidemic has caused a large number of human losses and havoc in the economic, social, societal, and health systems around the world. Controlling such epidemic requires understanding its characteristics and behavior, which can be identified by collecting and analyzing the related big data. Big data analytics tools play a vital role in building knowledge required in making decisions and precautionary measures. However, due to the vast amount of data available on COVID-19 from various sources, there is a need to review the roles of big data analysis in controlling the spread of COVID-19, presenting the main challenges and directions of COVID-19 data analysis, as well as providing a framework on the related existing applications and studies to facilitate future research on COVID-19 analysis. Therefore, in this paper, we conduct a literature review to highlight the contributions of several studies in the domain of COVID-19-based big data analysis. The study presents as a taxonomy several applications used to manage and control the pandemic. Moreover, this study discusses several challenges encountered when analyzing COVID-19 data. The findings of this paper suggest valuable future directions to be considered for further research and applications.


Assuntos
Big Data , Ciência de Dados , Pandemias , /epidemiologia , Humanos , Pandemias/prevenção & controle
7.
Sensors (Basel) ; 21(7)2021 Mar 30.
Artigo em Inglês | MEDLINE | ID: mdl-33808468

RESUMO

High stress levels and sleep deprivation may cause several mental or physical health issues, such as depression, impaired memory, decreased motivation, obesity, etc. The COVID-19 pandemic has produced unprecedented changes in our lives, generating significant stress, and worries about health, social isolation, employment, and finances. To this end, nowadays more than ever, it is crucial to deliver solutions that can help people to manage and control their stress, as well as to reduce sleep disturbances, so as to improve their health and overall quality of life. Technology, and in particular Ambient Intelligence Environments, can help towards that direction, when considering that they are able to understand the needs of their users, identify their behavior, learn their preferences, and act and react in their interest. This work presents two systems that have been designed and developed in the context of an Intelligent Home, namely CaLmi and HypnOS, which aim to assist users that struggle with stress and poor sleep quality, respectively. Both of the systems rely on real-time data collected by wearable devices, as well as contextual information retrieved from the ambient facilities of the Intelligent Home, so as to offer appropriate pervasive relaxation programs (CaLmi) or provide personalized insights regarding sleep hygiene (HypnOS) to the residents. This article will describe the design process that was followed, the functionality of both systems, the results of the user studies that were conducted for the evaluation of their end-user applications, and a discussion about future plans.


Assuntos
Higiene do Sono , Estresse Psicológico/prevenção & controle , Humanos , Pandemias , Qualidade de Vida , Terapia de Relaxamento , Software , Dispositivos Eletrônicos Vestíveis
8.
Artigo em Inglês | MEDLINE | ID: mdl-33819334

RESUMO

The efficacy of the socket preservation procedure using deproteinized bovine bone mineral, bioabsorbable collagen membrane, and collagen sponge on molar extraction sites with severe periodontitis was assessed at 6 postoperative months, before implant placement. Results revealed excellent soft tissue healing without loss of keratinized tissue and no statistically significant differences in socket marginal bone changes in 20 molar extraction sockets. High levels of primary implant stability were recorded. Socket preservation using a minimally invasive surgical technique provides good soft and hard tissue healing as well as anticipated stability of implant placement at sites of extracted molars with severe periodontitis.


Assuntos
Perda do Osso Alveolar , Periodontite , Perda do Osso Alveolar/prevenção & controle , Perda do Osso Alveolar/cirurgia , Animais , Bovinos , Humanos , Dente Molar/cirurgia , Periodontite/cirurgia , Extração Dentária , Alvéolo Dental/cirurgia
9.
Int J Pharm Compd ; 25(2): 131-139, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33798113

RESUMO

Intravenous admixture compounding is common practice in most hospitals throughout the world, regardless of the country. Compounding intravenous medications involves risk, as there is a high potential for error due to their complexity in compounding, and working in an aseptic environment itself poses issues for the compounder. Part 9-A of this series of articles on the topic of intravenous admixture preparation considerations discusses 1) the background, 2) types of errors, 3) where errors can occur, 4) automated parenteral nutrition compounding systems, 5) accuracy and strength issues, and 6) medication error prevention. Part 9-B of this series of articles will include 1) a discussion on standardization (of both formulas and procedures), 2) competency, 3) compliance, 4) a detailed table on the sources of errors, and 5) the considerations for the prevention of errors.


Assuntos
Erros de Medicação , Nutrição Parenteral , Administração Intravenosa , Composição de Medicamentos , Humanos , Erros de Medicação/prevenção & controle
10.
Wiad Lek ; 74(3 cz 1): 508-511, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33813459

RESUMO

OBJECTIVE: The aim: To clarify the efficacy of probiotics use as a preventive measure for post-antibiotic treatment in acute peritonitis and increase staff awareness related to antibiotic and probiotic use. PATIENTS AND METHODS: Materials and methods: The study design included determination of the proper antibiotic and probiotic strain combination and clinical application of probiotic strains. The control group consisted of 63 (48.46%) patients who underwent traditional multimodal treatment of peritonitis and the study group of 67 (51.54%) individuals, with inclusion of different antibiotic/probiotic combinations. RESULTS: Results: Prior to antimicrobial therapy 67.7% patients of both groups' patients had severe dysbiosis, proving dysbiosis as a sign of peritonitis. S. boulardii showed widest resistance spectrum and was used for probiotic therapy in study group. Intestinal dysbiosis grades distribution in control group significantly worsened, while in study group ratio of severe dysbiosis significantly dropped from 58.2% to 38.8% with significant growth of grade II dysbiosis to 61.2%. No visible differences in disease course and clinical picture, duration or complications rate between study and control groups were observed. CONCLUSION: Conclusions: Most of probiotic strains lack antibacterial resistance that makes meaningless their use during systemic antibiotic therapy of acute peritonitis. It is characterized by harsh changes of intestinal microbiota (severe intestinal dysbiosis). While probiotic strains showed antibiotic tolerance, their use presented no significant clinical efficacy, though high level of positive influence on intestinal dysbiosis was observed.


Assuntos
Microbioma Gastrointestinal , Peritonite , Probióticos , Antibacterianos/uso terapêutico , Disbiose/tratamento farmacológico , Humanos , Peritonite/tratamento farmacológico , Peritonite/prevenção & controle , Probióticos/uso terapêutico
11.
s.l; Organización Panamericana de la Salud; abr. 5, 2021. 4 p.
Não convencional em Espanhol | LILACS | ID: biblio-1177146

RESUMO

Cuba ya produce lotes monodosis que no contienen tiomersal de los tres candidatos vacunales Soberana contra la COVID-19, de modo que puedan beneficiarse personas que son alérgicas a esta sustancia, y que, en los actuales ensayos clínicos, quedan fuera por esta causa. También con el candidato vacunal Abdala se está trabajando a escala productiva en vacunas que no contendrán tiomersal, para utilizarlas en etapas futuras del desarrollo clínico. El candidato vacunal Mambisa es un spray nasal y el bulbo no contiene esa sustancia.


Assuntos
Humanos , Pneumonia Viral/prevenção & controle , Infecções por Coronavirus/prevenção & controle , Pandemias/estatística & dados numéricos , Cuba/epidemiologia
12.
Cas Lek Cesk ; 160(1): 37-39, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33823603

RESUMO

Effectiveness of the policy measures against the COVID-19 pandemic is reduced by spread of conspiracy theories. Moreover, conspiracy theories induce opposition to vaccines. The text shows that increased occurrence of conspiracy theories is a typical public reaction to a disaster and describes some of the mechanisms contributing to susceptibility to conspiracy explanations on the individual as well as societal level.


Assuntos
Pandemias , Humanos , Pandemias/prevenção & controle
13.
Int Breastfeed J ; 16(1): 30, 2021 03 31.
Artigo em Inglês | MEDLINE | ID: mdl-33789708

RESUMO

BACKGROUND: The World Health Organization recognizes exclusive breastfeeding a safe source of nutrition available for children in most humanitarian emergencies, as in the current pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Despite the Brazilian national guideline protecting breastfeeding practices, there are many concerns about protecting infants from their infected mothers. This study aimed to analyze how the Brazilian hospitals and maternity services promote and support mothers suspected or diagnosed with coronavirus disease (COVID-19). METHODS: This is a descriptive cross-sectional and multicenter study which collected data from 24 Brazilian hospitals and maternity services between March and July 2020. Representatives of the institutions completed a questionnaire based on acts to promote and support breastfeeding, the Baby-Friendly Hospital Initiative, and Brazil's federal law recommendations. RESULTS: The results showed that in delivery rooms, 98.5% of the services prohibited immediate and uninterrupted skin-to-skin contact between mothers and their infants and did not support mothers to initiate breastfeeding in the first hour. On the postnatal ward, 98.5% of the services allowed breastfeeding while implementing respiratory hygiene practices to prevent transmission of COVID-19. Companions for mothers were forbidden in 83.3% of the hospitals. Hospital discharge was mostly between 24 and 28 h (79.1%); discharge guidelines were not individualized. Additionally, a lack of support was noticed from the home environment's health community network (83.3%). Hospital and home breast pumping were allowed (87.5%), but breast milk donation was not accepted (95.8%). There was a lack of guidance regarding the use of infant comforting strategies. Guidelines specific for vulnerable populations were not covered in the material evaluated. CONCLUSIONS: In Brazil, hospitals have not followed recommendations to protect, promote, and support breastfeeding during the COVID-19 outbreak. The disagreement between international guidelines has been a major issue. The absence of recommendations on breastfeeding support during the pandemic led to difficulties in developing standards among hospitals in different regions of Brazil and other countries worldwide. The scientific community needs to discuss how to improve maternal and infant care services to protect breastfeeding in the current pandemic.


Assuntos
Aleitamento Materno , Fidelidade a Diretrizes , Higiene , Brasil/epidemiologia , Aleitamento Materno/efeitos adversos , /etiologia , Estudos Transversais , Surtos de Doenças/prevenção & controle , Feminino , Fidelidade a Diretrizes/estatística & dados numéricos , Hospitais , Humanos , Serviços de Saúde Materna , Pandemias , Gravidez , Inquéritos e Questionários
14.
Asia Pac J Ophthalmol (Phila) ; 10(2): 142-145, 2021 Mar 23.
Artigo em Inglês | MEDLINE | ID: mdl-33793439

RESUMO

ABSTRACT: Ophthalmologists and patients have an inherent increased risk for transmission of SARS-CoV-2. The human ocular surface expresses receptors and enzymes facilitating transmission of SARS-CoV-2. Personal protective equipment alone provides incomplete protection. Adjunctive topical ocular, nasal, and oral antisepsis with povidone iodine bolsters personal protective equipment in prevention of provider-patient transmission of SARS-CoV-2 in ophthalmology.


Assuntos
Anti-Infecciosos Locais/uso terapêutico , Desinfecção/métodos , Transmissão de Doença Infecciosa do Paciente para o Profissional/prevenção & controle , Transmissão de Doença Infecciosa do Profissional para o Paciente/prevenção & controle , Povidona-Iodo/uso terapêutico , Administração Oftálmica , Humanos , Soluções Oftálmicas , Equipamento de Proteção Individual , Exame Físico
15.
Anticancer Res ; 41(4): 2101-2110, 2021 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-33813420

RESUMO

BACKGROUND/AIM: To evaluate if topical support therapy during static-intensity modulated radiotherapy (sIMRT) course is able to equal the characteristic minimum risk for radiation proctitis of Image-guided volumetric modulated arc therapy (IG-VMAT) treatment among localized prostate cancer patients. PATIENTS AND METHODS: Rectal toxicity data of the above patients were retrospectively collected throughout three different clinical periods at our Radiotherapy Deparment: from October 2011 to December 2012, prostate cancer patients were treated with sIMRT and in advance supported by means of daily topical corticosteroids; from January 2013 to November 2016, topical corticosteroids were replaced by daily hyaluronic acid enemas; from December 2016 to May 2018 eligible patients were treated with newly introduced IG-VMAT supported by only on-demand topical corticosteroids. RESULTS: Among 359 eligible patients, IG-VMAT was proven generally more effective than sIMRT supported by topical medications in terms of proctitis reduction, although without clinical and practical relevance. CONCLUSION: Topical medications might have a role in radiation proctitis prevention.


Assuntos
Anti-Inflamatórios/administração & dosagem , Proctite/prevenção & controle , Neoplasias da Próstata/tratamento farmacológico , Neoplasias da Próstata/radioterapia , Radioterapia de Intensidade Modulada , Administração Tópica , Idoso , Idoso de 80 Anos ou mais , Beclometasona/administração & dosagem , Enema/métodos , Humanos , Ácido Hialurônico/administração & dosagem , Itália , Masculino , Pessoa de Meia-Idade , Tratamentos com Preservação do Órgão/métodos , Proctite/etiologia , Neoplasias da Próstata/patologia , Hipofracionamento da Dose de Radiação , Lesões por Radiação/prevenção & controle , Planejamento da Radioterapia Assistida por Computador/métodos , Radioterapia Guiada por Imagem/efeitos adversos , Radioterapia Guiada por Imagem/métodos , Radioterapia de Intensidade Modulada/efeitos adversos , Radioterapia de Intensidade Modulada/métodos , Estudos Retrospectivos
16.
Angiol Sosud Khir ; 27(1): 97-106, 2021.
Artigo em Russo | MEDLINE | ID: mdl-33825735

RESUMO

Surgical revascularization of the carotid basin in the acutest period of ischaemic stroke, i.e., within 72 hours, will make it possible to prevent the development of recurrent stroke by removing an embologenically dangerous atherosclerotic plaque of the symptomatic carotid artery and to improve cerebral blood supply, having eliminated haemodynamic stenosis of the carotid artery. However, the problem of safety of carotid endarterectomy in patients during the acutest period of ischaemic stroke still remains debatable. PURPOSE: To comparatively analyse safety of eversion carotid endarterectomy performed in the acutest (0-72 hours) and acute (4-14 days) periods of minor ischaemic stroke. PATIENTS AND METHODS: Between January 2015 and December 2019, specialists of the Department of Vascular Surgery of Municipal Clinical Hospital # 7 of Kazan performed a total of 80 eversion carotid reconstructions in the period of minor ischaemic stroke within 14 days. The patients were divided into 2 groups depending on the terms of performing carotid endarterectomy. The first group comprised 32 (40.0%) patients operated on in the acutest period of ischaemic stroke, i.e., within 72 hours from the onset of first symptoms of neurological deficit. The second group included 48 (60.0%) patients subjected to carotid endarterectomy within 4 to 14 days from the onset of first signs of neurological deficit. RESULTS: According to the obtained findings, haemorrhagic transformation in the early postoperative period occured in 2 Group Two patients, with one lethal outcome on POD 3. Cerebral ischaemia increased in one patient of each group without enlargement of the ischaemic zone according to brain computed tomography, with residual neurological deficit in Group I in remote period (Rankin scale score 1) and complete restoration in Group II (Rankin scale score 0). Recurrent minor ischaemic stroke on POD 1 developed in Group II with formation of a new lacunar region of ischaemia of the brain in the operated carotid basin and was verified by the findings of cerebral MRI with persisting neurological deficit for 6 months (Rankin scale score 2). The comparative assessment of severity of stroke on the day of operation and at discharge, as well as that of neurological symptomatology during the 1st and 6th months of follow up in both groups proved positive. No events of acute coronary syndrome, recurrent strokes or lethal outcomes were observed during the follow-up period. CONCLUSION: According to the findings of our study, patients with acute cerebral circulation impairment caused by embologenically dangerous lesions of internal carotid arteries should be operated on within the first 72 hours, if there are no accompanying changes requiring time for correction thereof.


Assuntos
Isquemia Encefálica , Estenose das Carótidas , Endarterectomia das Carótidas , Acidente Vascular Cerebral , Isquemia Encefálica/diagnóstico , Isquemia Encefálica/etiologia , Isquemia Encefálica/prevenção & controle , Estenose das Carótidas/complicações , Estenose das Carótidas/diagnóstico , Estenose das Carótidas/cirurgia , Endarterectomia das Carótidas/efeitos adversos , Humanos , Acidente Vascular Cerebral/diagnóstico , Acidente Vascular Cerebral/etiologia , Acidente Vascular Cerebral/prevenção & controle , Resultado do Tratamento
17.
Angiol Sosud Khir ; 27(1): 169-174, 2021.
Artigo em Russo | MEDLINE | ID: mdl-33825745

RESUMO

Hereditary thrombophilia is rare pathology giving rise to a ninefold increase in the risk for the development of thromboembolism in infants. The problem is multifactorial and characterized by high mortality, especially in neonates. Infants who develop thrombosis, particularly those with no family history, are often subjected to testing for hereditary thrombophilia. However, genetic testing for thrombophilia does not change the plan of treatment but makes it possible to perform prevention of thrombosis within the risk periods for the patient. Poor awareness of paediatricians, the complexity of carrying out genetic testing, the absence of approaches supported by evidence-based medicine due to shortage of high-quality clinical trials and no guidelines on prevention of thromboembolism in infants, as well as the frequent occurrence of diversified causes and diseases in different age groups make the problem significant for modern medicine. Further studies are needed to address many unanswered as yet questions.


Assuntos
Tromboembolia , Trombofilia , Trombose , Átrios do Coração/diagnóstico por imagem , Humanos , Lactente , Recém-Nascido , Fatores de Risco , Tromboembolia/diagnóstico , Tromboembolia/etiologia , Tromboembolia/prevenção & controle , Trombofilia/complicações , Trombofilia/diagnóstico , Trombofilia/genética , Veia Cava Inferior/diagnóstico por imagem
18.
Rev Bras Epidemiol ; 24: e210014, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33825774

RESUMO

OBJECTIVE: To investigate sociodemographic factors associated with the willingness to take the pandemic influenza vaccine. METHODS: This is a cross-sectional study of Brazilian civil servants participating in the fourth wave (2012-2013) of the longitudinal Pró-Saúde Study. Associations were expressed as odds ratios (OR) and 95% confidence intervals (95%CI), estimated by multivariate logistic regression models. RESULTS: Among 2,828 participants, 15.9% would not be willing to vaccinate in the future if the Brazilian Ministry of Health promoted a new vaccination campaign against pandemic influenza. Not willing to vaccinate in the future was strongly associated with not taking the pandemic influenza vaccine in 2010 (OR = 9.0, 95%CI 6.9 - 11.6). Among the unvaccinated, females, those aged > 60 years, and non-health care workers were less willing to vaccinate in the future. Again, in the vaccinated group, females were less willing to vaccinate. CONCLUSION: Multidisciplinary efforts should be encouraged in order to identify reasons for refusing vaccination, focusing on the individual and group perceptions of susceptibility, severity, benefits, and barriers to vaccination. Such information is needed to identify target groups for the delivery of customized interventions towards preventing emerging pandemics, such as avian influenza and COVID-19.


Assuntos
Empregados do Governo , Vírus da Influenza A Subtipo H1N1 , Vacinas contra Influenza , Influenza Humana , Aceitação pelo Paciente de Cuidados de Saúde , Vacinação , Brasil/epidemiologia , Estudos Transversais , Feminino , Empregados do Governo/psicologia , Empregados do Governo/estatística & dados numéricos , Humanos , Vacinas contra Influenza/administração & dosagem , Influenza Humana/epidemiologia , Influenza Humana/prevenção & controle , Masculino , Pessoa de Meia-Idade , Aceitação pelo Paciente de Cuidados de Saúde/estatística & dados numéricos , Vacinação/psicologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...